- Home
- ORGO vs ABSI Comparison
ORGO vs ABSI Comparison
Compare ORGO & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- ABSI
- Stock Information
- Founded
- ORGO 1985
- ABSI 2011
- Country
- ORGO United States
- ABSI United States
- Employees
- ORGO N/A
- ABSI N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- ORGO Health Care
- ABSI Health Care
- Exchange
- ORGO Nasdaq
- ABSI Nasdaq
- Market Cap
- ORGO 376.8M
- ABSI 347.0M
- IPO Year
- ORGO N/A
- ABSI 2021
- Fundamental
- Price
- ORGO $2.92
- ABSI $2.87
- Analyst Decision
- ORGO Buy
- ABSI Strong Buy
- Analyst Count
- ORGO 2
- ABSI 5
- Target Price
- ORGO $5.50
- ABSI $8.40
- AVG Volume (30 Days)
- ORGO 1.6M
- ABSI 3.0M
- Earning Date
- ORGO 05-08-2025
- ABSI 05-13-2025
- Dividend Yield
- ORGO N/A
- ABSI N/A
- EPS Growth
- ORGO N/A
- ABSI N/A
- EPS
- ORGO N/A
- ABSI N/A
- Revenue
- ORGO $458,760,000.00
- ABSI $4,815,000.00
- Revenue This Year
- ORGO $2.73
- ABSI $151.99
- Revenue Next Year
- ORGO $12.28
- ABSI $179.72
- P/E Ratio
- ORGO N/A
- ABSI N/A
- Revenue Growth
- ORGO 5.35
- ABSI N/A
- 52 Week Low
- ORGO $2.28
- ABSI $2.01
- 52 Week High
- ORGO $6.71
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- ORGO 35.44
- ABSI 48.64
- Support Level
- ORGO $2.61
- ABSI $2.59
- Resistance Level
- ORGO $3.28
- ABSI $2.95
- Average True Range (ATR)
- ORGO 0.14
- ABSI 0.15
- MACD
- ORGO 0.01
- ABSI 0.01
- Stochastic Oscillator
- ORGO 34.59
- ABSI 45.88
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.